1 Tada S, "Severe parkinsonism associated with anti-CRMP5 antibody-positive paraneoplastic neurological syndrome and abnormal signal intensity in the bilateral basal ganglia" 87 : 907-910, 2016
2 Graus F, "Recommended diagnostic criteria for paraneoplastic neurological syndromes" 75 : 1135-1140, 2004
3 Lancaster E, "Paraneoplastic disorders" 21 (21): 452-475, 2015
4 Golbe LI, "Paraneoplastic degeneration of the substantia nigra with dystonia and parkinsonism" 4 : 147-152, 1989
5 Kannoth S, "Autoimmune atypical parkinsonism-a group of treatable parkinsonism" 362 : 40-46, 2016
6 Pittock SJ, "Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments" 53 : 580-587, 2003